V-Square Quantitative Management’s Moderna MRNA Stock Holding History

V-Square Quantitative Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$254K	Sell	5,004 -4,994	-50%	-$233K	0.03%	489
2025 Q4	$295K	Sell	9,998 -513	-5%	-$13.9K	0.03%	441
2025 Q3	$271K	Buy	10,511 +390	+4%	+$10.9K	0.05%	168
2025 Q2	$279K	Buy	10,121 +2,614	+35%	+$68.8K	0.04%	433
2025 Q1	$213K	Sell	7,507 -290	-4%	-$10.3K	0.03%	489
2024 Q4	$324K	Buy	7,797 +2,148	+38%	+$103K	0.05%	398
2024 Q3	$378K	Buy	5,649 +2,838	+101%	+$261K	0.06%	367
2024 Q2	$334K	Sell	2,811 -967	-26%	-$122K	0.05%	342
2024 Q1	$403K	Buy	3,778 +1,280	+51%	+$129K	0.06%	317
2023 Q4	$248K	Buy	2,498 +666	+36%	+$56K	0.04%	349
2023 Q3	$189K	Buy	+1,832	New	+$204K	0.08%	378

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

V-Square Quantitative Management's MRNA Position: Q1 2026 in Review

V-Square Quantitative Management reduced its Moderna (MRNA) stake by 50% in Q1 2026, selling an estimated $233K and leaving 5,004 shares worth $254K. The position accounts for 0.03% of the portfolio, ranked #489.

V-Square Quantitative Management first reported a position in MRNA in Q3 2023 and has held it in 11 quarters since. The position peaked at $403K in Q1 2024. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

V-Square Quantitative Management held 5,004 shares of Moderna worth $254K as of Q1 2026.
V-Square Quantitative Management sold 4,994 Moderna shares in Q1 2026, an estimated $233K.
Moderna made up 0.03% of V-Square Quantitative Management's portfolio in Q1 2026, its #489 holding.
V-Square Quantitative Management first reported a position in Moderna in Q3 2023 and has held it in 11 quarters since.
V-Square Quantitative Management's Moderna position peaked at $403K in Q1 2024.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on V-Square Quantitative Management's 13F filing for Q1 2026, filed 27 Apr 2026.